DekaBank Deutsche Girozentrale’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.4M | Hold |
54,792
| – | – | 0.05% | 271 |
|
|
2026
Q1 | $31M | Hold |
54,792
| – | – | 0.05% | 271 |
|
|
2025
Q4 | $30.2M | Hold |
54,792
| – | – | 0.05% | 266 |
|
|
2025
Q3 | $34.5M | Hold |
54,792
| – | – | 0.06% | 256 |
|
|
2025
Q2 | $29.2M | Buy |
54,792
+2,535
| +5% | +$1.21M | 0.05% | 266 |
|
|
2025
Q1 | $21.6M | Sell |
52,257
-2,535
| -5% | -$1.1M | 0.04% | 302 |
|
|
2024
Q4 | $22.5M | Hold |
54,792
| – | – | 0.04% | 301 |
|
|
2024
Q3 | $27.9M | Buy |
54,792
+572
| +1% | +$278K | 0.05% | 274 |
|
|
2024
Q2 | $26.7M | Buy |
54,220
+1,963
| +4% | +$985K | 0.05% | 275 |
|
|
2024
Q1 | $28M | Buy |
52,257
+10,212
| +24% | +$5.58M | 0.05% | 268 |
|
|
2023
Q4 | $23.3M | Buy |
42,045
+3,627
| +9% | +$1.7M | 0.05% | 290 |
|
|
2023
Q3 | $16.7M | Buy |
38,418
+4,758
| +14% | +$2.37M | 0.04% | 332 |
|
|
2023
Q2 | $16.6M | Sell |
33,660
-1,200
| -3% | -$575K | 0.04% | 344 |
|
|
2023
Q1 | $17.1M | Sell |
34,860
-20,194
| -37% | -$9.66M | 0.04% | 316 |
|
|
2022
Q4 | $22.5M | Sell |
55,054
-3,881
| -7% | -$1.51M | 0.06% | 270 |
|
|
2022
Q3 | $19.3M | Buy |
58,935
+11,158
| +23% | +$4.1M | 0.06% | 266 |
|
|
2022
Q2 | $16.9M | Buy |
47,777
+15,946
| +50% | +$6.5M | 0.05% | 298 |
|
|
2022
Q1 | $17.6M | Buy |
31,831
+39
| +0.1% | +$20.5K | 0.04% | 311 |
|
|
2021
Q4 | $20.9M | Buy |
31,792
+1,663
| +6% | +$1.04M | 0.05% | 276 |
|
|
2021
Q3 | $19.1M | Sell |
30,129
-11,025
| -27% | -$7.41M | 0.05% | 266 |
|
|
2021
Q2 | $26.3M | Buy |
41,154
+12,733
| +45% | +$7.03M | 0.08% | 224 |
|
|
2021
Q1 | $13.5M | Buy |
28,421
+7,364
| +35% | +$3.69M | 0.04% | 298 |
|
|
2020
Q4 | $10.4M | Buy |
21,057
+5,167
| +33% | +$2.31M | 0.04% | 322 |
|
|
2020
Q3 | $6.07M | Buy |
15,890
+244
| +2% | +$90.2K | 0.03% | 362 |
|
|
2020
Q2 | $5.11M | Sell |
15,646
-2,043
| -12% | -$592K | 0.03% | 311 |
|
|
2020
Q1 | $4.25M | Buy |
17,689
+1,068
| +6% | +$279K | 0.03% | 299 |
|
|
2019
Q4 | $4.38M | Sell |
16,621
-7,966
| -32% | -$2.1M | 0.03% | 362 |
|
|
2019
Q3 | $6.76M | Sell |
24,587
-2,840
| -10% | -$790K | 0.04% | 315 |
|
|
2019
Q2 | $7.55M | Buy |
27,427
+4,564
| +20% | +$1.12M | 0.04% | 353 |
|
|
2019
Q1 | $5.9M | Buy |
22,863
+737
| +3% | +$152K | 0.04% | 394 |
|
|
2018
Q4 | $4.2M | Sell |
22,126
-737
| -3% | -$151K | 0.03% | 391 |
|
|
2018
Q3 | $5.9M | Buy |
22,863
+5,299
| +30% | +$1.29M | 0.03% | 399 |
|
|
2018
Q2 | $3.89M | Buy |
17,564
+4,524
| +35% | +$932K | 0.03% | 460 |
|
|
2018
Q1 | $2.56M | Sell |
13,040
-6,050
| -32% | -$1.12M | 0.02% | 520 |
|
|
2017
Q4 | $3.03M | Hold |
19,090
| – | – | 0.02% | 477 |
|
|
2017
Q3 | $3.03M | Buy |
19,090
+2,855
| +18% | +$451K | 0.02% | 482 |
|
|
2017
Q2 | $2.68M | Buy |
16,235
+9,316
| +135% | +$1.51M | 0.02% | 490 |
|
|
2017
Q1 | $1.11M | Buy |
6,919
+3,918
| +131% | +$540K | 0.01% | 603 |
|
|
2016
Q4 | $354K | Sell |
3,001
-449
| -13% | -$51.2K | ﹤0.01% | 720 |
|
|
2016
Q3 | $388K | Sell |
3,450
-550
| -14% | -$58K | ﹤0.01% | 712 |
|
|
2016
Q2 | $366K | Buy |
+4,000
| New | +$344K | ﹤0.01% | 739 |
|
Other funds holding IDXX
MBI
CGI
DekaBank Deutsche Girozentrale's IDXX Position: Q2 2026 in Review
DekaBank Deutsche Girozentrale held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 54,792 shares worth $30.4M. The position accounts for 0.05% of the portfolio, ranked #271.
DekaBank Deutsche Girozentrale first reported a position in IDXX in Q2 2016 and has held it in 41 quarters since. The position peaked at $34.5M in Q3 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- DekaBank Deutsche Girozentrale held 54,792 shares of Idexx Laboratories worth $30.4M as of Q2 2026.
- DekaBank Deutsche Girozentrale left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up 0.05% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #271 holding.
- DekaBank Deutsche Girozentrale first reported a position in Idexx Laboratories in Q2 2016 and has held it in 41 quarters since.
- DekaBank Deutsche Girozentrale's Idexx Laboratories position peaked at $34.5M in Q3 2025.
- 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.